You have 9 free searches left this month | for more free features.

itacitinib

Showing 1 - 25 of 39

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bronchiolitis Obliterans Trial in Houston (Itacitinib, Itacitinib Adipate)

Recruiting
  • Bronchiolitis Obliterans
  • Itacitinib
  • Itacitinib Adipate
  • Houston, Texas
    M D Anderson Cancer Center
Jan 24, 2023

Classical Hodgkin Lymphoma Trial in Philadelphia (Itacitinib, Everolimus)

Active, not recruiting
  • Classical Hodgkin Lymphoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Nov 28, 2022

Diffuse Large B Cell Lymphoma Trial in Tampa (Itacitinib, Chimeric antigen receptor (CAR) T-cell therapy)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Itacitinib
  • Chimeric antigen receptor (CAR) T-cell therapy
  • Tampa, Florida
    Moffitt Cancer Center
Mar 6, 2023

Chronic Graft-versus-host-disease Trial in Salt Lake City (Itacitinib, Extracorporeal Photopheresis (ECP))

Active, not recruiting
  • Chronic Graft-versus-host-disease
  • Itacitinib
  • Extracorporeal Photopheresis (ECP)
  • Salt Lake City, Utah
    Huntsman Cancer Institute at University of Utah
Jan 30, 2023

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Nashville (Itacitinib, Corticosteroid, Endoscopic

Not yet recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Itacitinib
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 20, 2022

Adults Patients Having Non Severe HLH Trial in Bobigny (Itacitinib)

Recruiting
  • Adults Patients Having Non Severe HLH
  • Itacitinib
  • Bobigny, France
    Hôpital Avicenne
Aug 22, 2022

Leukemia, Acute, MDS, Myelomonocytic Leukemia, Chronic Trial (Itacitinib)

Not yet recruiting
  • Leukemia, Acute
  • +7 more
  • Itacitinib
  • (no location specified)
Apr 10, 2023

STAT1 Gain-of-Function Disease Trial (Itacitinib)

Available
  • STAT1 Gain-of-Function Disease
  • Itacitinib
  • (no location specified)
Sep 30, 2022

Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle

Recruiting
  • Metastatic Leiomyosarcoma
  • +17 more
  • Itacitinib
  • Laboratory Biomarker Analysis
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 13, 2022

Bronchiolitis Obliterans Syndrome Trial in Belgium, Canada, United States (Itacitinib)

Active, not recruiting
  • Bronchiolitis Obliterans Syndrome
  • Itacitinib
  • Los Angeles, California
  • +8 more
Oct 14, 2022

Cytokine Release Syndrome Trial in United States (Itacitinib, Immune effector cell therapy, Placebo)

Recruiting
  • Cytokine Release Syndrome
  • Itacitinib
  • +3 more
  • Miami, Florida
  • +9 more
Oct 25, 2022

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, MDS Trial in Saint Louis (procedure, drug, other)

Recruiting
  • Acute Myelogenous Leukemia
  • +4 more
  • Stem cell transplantation
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 23, 2022

Myelofibrosis Trial in Canada, United States (itacitinib)

Recruiting
  • Myelofibrosis
  • itacitinib
  • Aurora, Colorado
  • +4 more
Mar 8, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Chronic Graft-versus-host-disease Trial in United States (Itacitinib)

Recruiting
  • Chronic Graft-versus-host-disease
  • Itacitinib
  • Denver, Colorado
  • +4 more
Jan 24, 2022

Hematologic and Lymphocytic Disorder Trial in Houston (Allogeneic Hematopoietic Stem Cell Transplantation, Busulfan,

Recruiting
  • Hematologic and Lymphocytic Disorder
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 1, 2022

Lymphoma Trial in United States (itacitinib, ibrutinib)

Completed
  • Lymphoma
  • Scottsdale, Arizona
  • +20 more
Nov 14, 2022

Systemic Sclerosis Trial in France (Itacitinib, Placebo)

Not yet recruiting
  • Systemic Sclerosis
  • Itacitinib
  • Placebo
  • Amiens, France
  • +33 more
Jun 7, 2022

Hematologic Malignancies Trial in Worldwide (Itacitinib, Calcineurin inhibitor)

Terminated
  • Hematologic Malignancies
  • Itacitinib
  • Calcineurin inhibitor
  • Aurora, Colorado
  • +16 more
Apr 29, 2022

Myelofibrosis, Polycythemia Vera, Thrombocythemia Trial in Worldwide (itacitinib)

Active, not recruiting
  • Myelofibrosis
  • +2 more
  • itacitinib
  • New Orleans, Louisiana
  • +20 more
Aug 25, 2022

MPN (Myeloproliferative Tumors) Trial in Australia, Canada, United States (itacitinib)

Completed
  • MPN (Myeloproliferative Neoplasms)
  • itacitinib
  • Birmingham, Alabama
  • +21 more
Aug 25, 2021

MDS/MPN Trial in Nashville (ASTX727, Itacitinib)

Recruiting
  • MDS/MPN
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Jun 20, 2022

Colorectal Cancer (CRC), Endometrial Cancer, Melanoma Trial in United States (Pembrolizumab, itacitinib, INCB050465)

Completed
  • Colorectal Cancer (CRC)
  • +10 more
  • San Francisco, California
  • +16 more
Mar 30, 2022

Lung Cancer Trial in Worldwide (Itacitinib, Osimertinib)

Active, not recruiting
  • Lung Cancer
  • La Jolla, California
  • +30 more
Mar 8, 2022

Allogeneic Stem Cell Transplant Recipient, Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid Cell Tumor Trial in

Withdrawn
  • Allogeneic Stem Cell Transplant Recipient
  • +2 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 27, 2020